SEC Form 4 · accession 0001179110-18-002366
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig Barrows
Officer — Vice-President,General Counsel
Period of report
Feb 15, 2018
Accepted (ET)
Feb 20, 2018 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $10.65 | Feb 15, 2018 | A | 225,000 | A | Feb 15, 2019 | Feb 15, 2028 | Common stock | 225,000 | 225,000 | D |
Explanation of responses
- F1Exercisable in three equal installments over the next three years starting on the first year anniversary of the grant.